HIND Latest Press Releases

-- August 25, 2026 --

Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet Business Wire 8:00 AM

-- July 1, 2026 --

Vyome Granted Chinese Patent Strengthening Immuno-Inflammation Portfolio Business Wire 8:00 AM

-- May 28, 2026 --

Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet Business Wire 8:00 AM

-- May 12, 2026 --

Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity Business Wire 8:00 AM

-- April 22, 2026 --

Vyome Presents Transformational VT-1953 Phase 2 Clinical Study Data at Prestigious AACR 2026 Business Wire 8:00 AM

-- April 6, 2026 --

Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026 Business Wire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software